SELECTA BIOSCIENCES, INC. WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • March 30th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2016 Company Industry JurisdictionThis Warrant to Purchase Common Stock (this “Warrant”) is issued to or its registered assigns by Selecta Biosciences, Inc., a Delaware corporation (the “Company”). This Warrant is one of several like warrants (collectively, the “Warrants”) being issued in connection with the issuance by the Company to the holder (the “Holder”) of shares of the Company’s Series E Convertible Preferred Stock, $0.0001 par value per share, pursuant to that certain Series E Preferred Stock Purchase Agreement by and among the Company, the Holder and the other parties named therein, dated as of August 27, 2015 (the “Purchase Agreement”). By its acceptance hereof, the Holder hereby agrees to be bound by the terms and conditions of this Warrant.
SELECTA BIOSCIENCES, INC. WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • March 30th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2016 Company Industry JurisdictionThis Warrant to Purchase Common Stock (this “Warrant”) is issued to or its registered assigns by Selecta Biosciences, Inc., a Delaware corporation (the “Company”). This Warrant is one of several like warrants (collectively, the “Warrants”) being issued in connection with the issuance by the Company to the holder (the “Holder”) of one or more Secured Convertible Promissory Notes (each, a “Note”) pursuant to that certain Securities Purchase Agreement by and among the Company, the Holder and the other parties named therein, dated as of April 10, 2015. By its acceptance hereof, the Holder hereby agrees to be bound by the terms and conditions of this Warrant.